Skip to main content
Journal cover image

Uveal Melanoma Treated With Iodine-125 Episcleral Plaque According to the COMS Trial Is Associated With Worsened Visual Acuity Change and Increased Risk of Chronic Toxicity Compared to Lower Prescription Doses

Publication ,  Conference
Perez, BA; Mettu, P; Vajzovic, L; Alkaissi, A; Steffey, BA; Cai, J; Stinnett, S; Mruthyunjaya, P; Kirsch, DG
Published in: International Journal of Radiation Oncology*Biology*Physics
September 2014

Duke Scholars

Published In

International Journal of Radiation Oncology*Biology*Physics

DOI

ISSN

0360-3016

Publication Date

September 2014

Volume

90

Issue

1

Start / End Page

S306 / S306

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 5105 Medical and biological physics
  • 3407 Theoretical and computational chemistry
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 0299 Other Physical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Perez, B. A., Mettu, P., Vajzovic, L., Alkaissi, A., Steffey, B. A., Cai, J., … Kirsch, D. G. (2014). Uveal Melanoma Treated With Iodine-125 Episcleral Plaque According to the COMS Trial Is Associated With Worsened Visual Acuity Change and Increased Risk of Chronic Toxicity Compared to Lower Prescription Doses. In International Journal of Radiation Oncology*Biology*Physics (Vol. 90, pp. S306–S306). Elsevier BV. https://doi.org/10.1016/j.ijrobp.2014.05.1023
Perez, B. A., P. Mettu, L. Vajzovic, A. Alkaissi, B. A. Steffey, J. Cai, S. Stinnett, P. Mruthyunjaya, and D. G. Kirsch. “Uveal Melanoma Treated With Iodine-125 Episcleral Plaque According to the COMS Trial Is Associated With Worsened Visual Acuity Change and Increased Risk of Chronic Toxicity Compared to Lower Prescription Doses.” In International Journal of Radiation Oncology*Biology*Physics, 90:S306–S306. Elsevier BV, 2014. https://doi.org/10.1016/j.ijrobp.2014.05.1023.
Perez BA, Mettu P, Vajzovic L, Alkaissi A, Steffey BA, Cai J, et al. Uveal Melanoma Treated With Iodine-125 Episcleral Plaque According to the COMS Trial Is Associated With Worsened Visual Acuity Change and Increased Risk of Chronic Toxicity Compared to Lower Prescription Doses. In: International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2014. p. S306–S306.
Perez, B. A., et al. “Uveal Melanoma Treated With Iodine-125 Episcleral Plaque According to the COMS Trial Is Associated With Worsened Visual Acuity Change and Increased Risk of Chronic Toxicity Compared to Lower Prescription Doses.” International Journal of Radiation Oncology*Biology*Physics, vol. 90, no. 1, Elsevier BV, 2014, pp. S306–S306. Crossref, doi:10.1016/j.ijrobp.2014.05.1023.
Perez BA, Mettu P, Vajzovic L, Alkaissi A, Steffey BA, Cai J, Stinnett S, Mruthyunjaya P, Kirsch DG. Uveal Melanoma Treated With Iodine-125 Episcleral Plaque According to the COMS Trial Is Associated With Worsened Visual Acuity Change and Increased Risk of Chronic Toxicity Compared to Lower Prescription Doses. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2014. p. S306–S306.
Journal cover image

Published In

International Journal of Radiation Oncology*Biology*Physics

DOI

ISSN

0360-3016

Publication Date

September 2014

Volume

90

Issue

1

Start / End Page

S306 / S306

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 5105 Medical and biological physics
  • 3407 Theoretical and computational chemistry
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 0299 Other Physical Sciences